Complementary treatment with oral pidotimod plus vitamin C after laser vaporization for female genital warts: a prospective study
- PMID: 20945819
- PMCID: PMC3019002
Complementary treatment with oral pidotimod plus vitamin C after laser vaporization for female genital warts: a prospective study
Abstract
This is a prospective study to assess a complementary treatment for genital warts after laser vaporization. 62 patients were enrolled in two randomized groups: Al: laser vaporization alone. A2: laser vaporization, followed with Pidotimod plus vitamin C for 2 1/2 months. The latter treatment shortened the time of warts remission and marginally decreased the rate of the warts' recurrence: 81% versus 67% (N.S.). Despite the non-significant difference, this complementary treatment seems to have some efficiency.
References
-
- Du Xiao F, Jiang CZ, Wu CF. Synergistic immunostimulatory effect of pidotimod and red ginseng acidic polysaccharide on humoral immunity of immunosuppressed mice . Pharmazie. 2008;63:904–908. - PubMed
-
- Pasqui AL, Bruni F, Di Renzo M. Pidotimod, a new biological response modifier, is able to partially prevent immune response changes related to surgical stress . Drugs Exp Clin Res. 1993;19:45–53. - PubMed
-
- Riboldi P. Pidotimod: a reappraisal . Int J Immunopathol Pharmacol. 2009;22:255–262. - PubMed
-
- Giuliano AR. HPV Natural History Study. Dietary intake and risk of persistent human papillomavirus (HPV) infection: the Ludwig–McGill HPV Natural History Study . J Infect Dis. 2003;188:1508–1516. - PubMed
-
- SyrjȨnen K. Mechanisms and predictors of high–risk human papillomavirus (HPV) clearance in the uterine cervix . Eur J Gynaecol Oncol. 2007;28:337–351. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous